Evaluation of the effects of rationally designed anti-TrkB peptides on the proliferation and apoptosis of multiple myeloma cells Online publication date: Sat, 03-Dec-2016
by Marzieh Kafshdouziamin; Mansour Poorebrahim; Hamzeh Rahimi; Morteza Karimipoor; Nematollah Gheibi
International Journal of Bioinformatics Research and Applications (IJBRA), Vol. 12, No. 4, 2016
Abstract: Inhibition of oncogenes through use of small peptides has emerged as a new promising approach in cancer therapy. TrkB is a proto-oncogene that its up-regulation has frequently been reported in the Multiple Myeloma (MM) cells. In our previous study, we have designed two potent inhibitory peptides based on the TrkB structure. Here, we have evaluated the effects of these anti-TrkB peptides on the proliferation and apoptosis of MM cell lines. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and flow cytometry were used to measure the cell viability and apoptosis of two MM cell lines treated with designed peptides. The effects of designed peptides on the expression and phosphorylation of TrkB were assessed using western blot assay. These designed peptides could efficiently modulate cell proliferation and apoptosis of MM cells through inhibiting TrkB phosphorylation. Our results indicate that the inhibitory anti-TrkB small peptides are very potent to inhibit MM cell proliferation through blocking TrkB signalling pathway.
Online publication date: Sat, 03-Dec-2016
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Bioinformatics Research and Applications (IJBRA):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email email@example.com